Igf-binding protein-derived peptide or small molecule
CA 2501057 A1 · Owner: Bioexpertise, Llc · Inventors: Mascarenhas, Desmond
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
New compositions based on IGF-binding sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 2, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.